Toxicities Associated with PARP Inhibitors in Ovarian Cancer

August 2, 2017
Ursula A. Matulonis, MD

Ursula A. Matulonis, MD, professor of Medicine, Harvard Medical School, medical director of Gynecologic Oncology, Dana-Farber Cancer Institute, discusses the toxicities that are associated with PARP inhibitors in ovarian cancer.